Cargando…

Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids

Medulloblastoma (MB), a neuroectodermal tumor arising in the cerebellum, represents the most frequent childhood brain malignancy. Current treatments for MB combine radiation and chemotherapy and are often associated with relevant side effects; novel therapeutic strategies are urgently needed. N-(4-H...

Descripción completa

Detalles Bibliográficos
Autores principales: Bassani, Barbara, Bartolini, Desirèe, Pagani, Arianna, Principi, Elisa, Zollo, Massimo, Noonan, Douglas M., Albini, Adriana, Bruno, Antonino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930187/
https://www.ncbi.nlm.nih.gov/pubmed/27367907
http://dx.doi.org/10.1371/journal.pone.0154111
_version_ 1782440709769396224
author Bassani, Barbara
Bartolini, Desirèe
Pagani, Arianna
Principi, Elisa
Zollo, Massimo
Noonan, Douglas M.
Albini, Adriana
Bruno, Antonino
author_facet Bassani, Barbara
Bartolini, Desirèe
Pagani, Arianna
Principi, Elisa
Zollo, Massimo
Noonan, Douglas M.
Albini, Adriana
Bruno, Antonino
author_sort Bassani, Barbara
collection PubMed
description Medulloblastoma (MB), a neuroectodermal tumor arising in the cerebellum, represents the most frequent childhood brain malignancy. Current treatments for MB combine radiation and chemotherapy and are often associated with relevant side effects; novel therapeutic strategies are urgently needed. N-(4-Hydroxyphenyl) retinamide (4-HPR, fenretinide), a synthetic analogue of all-trans retinoic acid, has emerged as a promising and well-tolerated cancer chemopreventive and chemotherapeutic agent for various neoplasms, from breast cancer to neuroblastoma. Here we investigated the effects of 4-HPR on MB cell lines and identified the mechanism of action for a potential use in therapy of MB. Flow cytometry analysis was performed to evaluate 4-HPR induction of apoptosis and oxygen reactive species (ROS) production, as well as cell cycle effects. Functional analysis to determine 4-HPR ability to interfere with MB cell migration and invasion were performed. Western Blot analysis were used to investigate the crucial molecules involved in selected signaling pathways associated with apoptosis (caspase-9 and PARP-1), cell survival (ERK 1/2) and tumor progression (Wnt3a and β-catenin). We show that 4-HPR induces caspase 9-dependent cell death in DAOY and ONS-76 cells, associated with increased ROS generation, suggesting that free radical intermediates might be directly involved. We observed 4-HPR induction of cell cycle arrest in G1/S phase, inactivated β-catenin, and inhibition of MB cell migration and invasion. We also evaluated the ability of 4-HPR to target MB cancer-stem/cancer-initiating cells, using an MB spheroids model, followed by flow cytometry and quantitative real-time PCR. 4-HPR treatment reduced DAOY and ONS-76 spheroid formation, in term of number and size. Decreased expression of the surface markers CD133(+) and ABCG2(+) as well as Oct-4 and Sox-2 gene expression were observed on BTICs treated with 4-HPR further reducing BITIC invasive activities. Finally, we analyzed 4-HPR ability to inhibit MB tumor cell growth in vivo in nude mice. Taken together, our data suggest that 4-HPR targets both parental and MB tumor stem/initiating cell-like populations. Since 4-HPR exerts low toxicity, it could represent a valid compound in the treatment of human MB.
format Online
Article
Text
id pubmed-4930187
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49301872016-07-18 Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids Bassani, Barbara Bartolini, Desirèe Pagani, Arianna Principi, Elisa Zollo, Massimo Noonan, Douglas M. Albini, Adriana Bruno, Antonino PLoS One Research Article Medulloblastoma (MB), a neuroectodermal tumor arising in the cerebellum, represents the most frequent childhood brain malignancy. Current treatments for MB combine radiation and chemotherapy and are often associated with relevant side effects; novel therapeutic strategies are urgently needed. N-(4-Hydroxyphenyl) retinamide (4-HPR, fenretinide), a synthetic analogue of all-trans retinoic acid, has emerged as a promising and well-tolerated cancer chemopreventive and chemotherapeutic agent for various neoplasms, from breast cancer to neuroblastoma. Here we investigated the effects of 4-HPR on MB cell lines and identified the mechanism of action for a potential use in therapy of MB. Flow cytometry analysis was performed to evaluate 4-HPR induction of apoptosis and oxygen reactive species (ROS) production, as well as cell cycle effects. Functional analysis to determine 4-HPR ability to interfere with MB cell migration and invasion were performed. Western Blot analysis were used to investigate the crucial molecules involved in selected signaling pathways associated with apoptosis (caspase-9 and PARP-1), cell survival (ERK 1/2) and tumor progression (Wnt3a and β-catenin). We show that 4-HPR induces caspase 9-dependent cell death in DAOY and ONS-76 cells, associated with increased ROS generation, suggesting that free radical intermediates might be directly involved. We observed 4-HPR induction of cell cycle arrest in G1/S phase, inactivated β-catenin, and inhibition of MB cell migration and invasion. We also evaluated the ability of 4-HPR to target MB cancer-stem/cancer-initiating cells, using an MB spheroids model, followed by flow cytometry and quantitative real-time PCR. 4-HPR treatment reduced DAOY and ONS-76 spheroid formation, in term of number and size. Decreased expression of the surface markers CD133(+) and ABCG2(+) as well as Oct-4 and Sox-2 gene expression were observed on BTICs treated with 4-HPR further reducing BITIC invasive activities. Finally, we analyzed 4-HPR ability to inhibit MB tumor cell growth in vivo in nude mice. Taken together, our data suggest that 4-HPR targets both parental and MB tumor stem/initiating cell-like populations. Since 4-HPR exerts low toxicity, it could represent a valid compound in the treatment of human MB. Public Library of Science 2016-07-01 /pmc/articles/PMC4930187/ /pubmed/27367907 http://dx.doi.org/10.1371/journal.pone.0154111 Text en © 2016 Bassani et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Bassani, Barbara
Bartolini, Desirèe
Pagani, Arianna
Principi, Elisa
Zollo, Massimo
Noonan, Douglas M.
Albini, Adriana
Bruno, Antonino
Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids
title Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids
title_full Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids
title_fullStr Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids
title_full_unstemmed Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids
title_short Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids
title_sort fenretinide (4-hpr) targets caspase-9, erk 1/2 and the wnt3a/β-catenin pathway in medulloblastoma cells and medulloblastoma cell spheroids
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930187/
https://www.ncbi.nlm.nih.gov/pubmed/27367907
http://dx.doi.org/10.1371/journal.pone.0154111
work_keys_str_mv AT bassanibarbara fenretinide4hprtargetscaspase9erk12andthewnt3abcateninpathwayinmedulloblastomacellsandmedulloblastomacellspheroids
AT bartolinidesiree fenretinide4hprtargetscaspase9erk12andthewnt3abcateninpathwayinmedulloblastomacellsandmedulloblastomacellspheroids
AT paganiarianna fenretinide4hprtargetscaspase9erk12andthewnt3abcateninpathwayinmedulloblastomacellsandmedulloblastomacellspheroids
AT principielisa fenretinide4hprtargetscaspase9erk12andthewnt3abcateninpathwayinmedulloblastomacellsandmedulloblastomacellspheroids
AT zollomassimo fenretinide4hprtargetscaspase9erk12andthewnt3abcateninpathwayinmedulloblastomacellsandmedulloblastomacellspheroids
AT noonandouglasm fenretinide4hprtargetscaspase9erk12andthewnt3abcateninpathwayinmedulloblastomacellsandmedulloblastomacellspheroids
AT albiniadriana fenretinide4hprtargetscaspase9erk12andthewnt3abcateninpathwayinmedulloblastomacellsandmedulloblastomacellspheroids
AT brunoantonino fenretinide4hprtargetscaspase9erk12andthewnt3abcateninpathwayinmedulloblastomacellsandmedulloblastomacellspheroids